Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD)

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 28, 2012

Primary Completion Date

May 27, 2015

Study Completion Date

May 27, 2015

Conditions
COPD
Interventions
DIETARY_SUPPLEMENT

Hydrolyzed casein protein

Amount provided is based on the fat-free mass of subject

DIETARY_SUPPLEMENT

Hydrolyzed casein protein + carbohydrates

Amount provided is based on the fat-free mass of subject

DIETARY_SUPPLEMENT

Hydrolyzed casein protein + leucine

Amount provided is based on the fat-free mass of subject. Leucine (40% of essential amino acid content)

DIETARY_SUPPLEMENT

Hydrolyzed casein protein + carbohydrates + leucine

Amount provided is based on the fat-free mass of subject. Leucine (40% of essential amino acid content)

DIETARY_SUPPLEMENT

4 levels of hydrolyzed casein protein + carbohydrates

Amount provided is based on the fat-free mass of subject. The 4 levels are: 0, 0.02, 0.05, 0.15 g casein protein/kg fat free mass/hr. The ratio between protein and carbohydrates is fixed.

Trial Locations (1)

77843

Texas A&M University, College Station

All Listed Sponsors
lead

Texas A&M University

OTHER

NCT01734473 - Casein Protein and Leucine Supplementation in Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter